Appearance of extrapyramidal symptoms: interaction between neuroleptics and other CNS active drugs.
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001285:Atropine / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D002491:Central Nervous System Agents / Q000494:pharmacology*; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D009048:Motor Skills / Q000187:drug effects; D010862:Pilocarpine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012702:Serotonin Antagonists / Q000494:pharmacology
D014150:Antipsychotic Agents; D001337:Autonomic Agents; D002491:Central Nervous System Agents; D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D010862:Pilocarpine; D001285:Atropine